Safety, Effectiveness, and Costs of Bevacizumab-Based Therapy in Southern Spain: A Real World Experience

• Published in: Medicine (Baltimore) Vol. 95; no. 19; p. e3623
• Main Authors: Marín-Pozo, Juan F, Duarte-Pérez, Juan M, Sánchez-Rovira, Pedro
• Format: Journal Article
• Language: English
• Published: United States Wolters Kluwer Health 01.05.2016
• Subjects: Aged; Angiogenesis Inhibitors - economics; Angiogenesis Inhibitors - therapeutic use; Bevacizumab - economics; Bevacizumab - therapeutic use; Female; Humans; Male; Middle Aged; Neoplasms - drug therapy; Observational Study; Off-Label Use - statistics & numerical data; Retrospective Studies; Spain; Time Factors

To evaluate the safety and efficacy of bevacizumab in a broader patient population with solid tumors in the context of general clinical practice. Moreover, we quantified the economic impact and characterized the off-label use (OLU) of this agent in real-life prescribing practices.This is an open, re...